Immunogenicity and safety of a novel MMR vaccine (live, freeze-dried) containing the Edmonston-Zagreb measles strain, the Hoshino mumps strain, and the RA 27/3 rubella strain: Results of a randomized, comparative, active controlled phase III clinical trial

• Главные авторы: Ashwani Sood (Автор), Monjori Mitra (Автор), Himanshu Arvind Joshi (Автор), Uma Siddhartha Nayak (Автор), Prashanth Siddaiah (Автор), T. Ramesh Babu (Автор), Samarendra Mahapatro (Автор), Jayesh Sanmukhani (Автор), Gaurav Gupta (Автор), Ravindra Mittal (Автор), Reinhard Glueck (Автор)
• Формат: ‌
• Опубликовано: Taylor & Francis Group, 2017-07-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

This phase III clinical trial was conducted to evaluate the immunogenicity and safety of the single-dose and multi-dose formulations of a novel MMR vaccine (live, freeze-dried) developed by M/s Cadila Healthcare Limited, India (Cadila MMR vaccine), containing the Hoshino mumps strain, compared to th...